184 related articles for article (PubMed ID: 19168054)
1. Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect.
Rollema H; Guanowsky V; Mineur YS; Shrikhande A; Coe JW; Seymour PA; Picciotto MR
Eur J Pharmacol; 2009 Mar; 605(1-3):114-6. PubMed ID: 19168054
[TBL] [Abstract][Full Text] [Related]
2. Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380.
Caldarone BJ; Wang D; Paterson NE; Manzano M; Fedolak A; Cavino K; Kwan M; Hanania T; Chellappan SK; Kozikowski AP; Olivier B; Picciotto MR; Ghavami A
Psychopharmacology (Berl); 2011 Sep; 217(2):199-210. PubMed ID: 21487659
[TBL] [Abstract][Full Text] [Related]
3. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex.
Rollema H; Wilson GG; Lee TC; Folgering JH; Flik G
Neurochem Int; 2011 Jan; 58(1):78-84. PubMed ID: 21056607
[TBL] [Abstract][Full Text] [Related]
4. Combined α7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: a comparison of SSR180711 and PNU-282987.
Andreasen JT; Redrobe JP; Nielsen EØ
Pharmacol Biochem Behav; 2012 Jan; 100(3):624-9. PubMed ID: 22108649
[TBL] [Abstract][Full Text] [Related]
5. Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.
Ortiz NC; O'Neill HC; Marks MJ; Grady SR
Nicotine Tob Res; 2012 Jun; 14(6):711-9. PubMed ID: 22241831
[TBL] [Abstract][Full Text] [Related]
6. The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
Cunningham CS; McMahon LR
Eur J Pharmacol; 2011 Mar; 654(1):47-52. PubMed ID: 21172344
[TBL] [Abstract][Full Text] [Related]
7. Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.
Andreasen JT; Nielsen EØ; Christensen JK; Olsen GM; Peters D; Mirza NR; Redrobe JP
J Psychopharmacol; 2011 Oct; 25(10):1347-56. PubMed ID: 20360159
[TBL] [Abstract][Full Text] [Related]
8. Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.
Turner JR; Wilkinson DS; Poole RL; Gould TJ; Carlson GC; Blendy JA
Neuropsychopharmacology; 2013 Sep; 38(10):2035-47. PubMed ID: 23624742
[TBL] [Abstract][Full Text] [Related]
9. Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.
Turner JR; Castellano LM; Blendy JA
J Pharmacol Exp Ther; 2010 Aug; 334(2):665-72. PubMed ID: 20435920
[TBL] [Abstract][Full Text] [Related]
10. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.
Mihalak KB; Carroll FI; Luetje CW
Mol Pharmacol; 2006 Sep; 70(3):801-5. PubMed ID: 16766716
[TBL] [Abstract][Full Text] [Related]
11. The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.
Wildeboer-Andrud KM; Stevens KE
Pharmacol Biochem Behav; 2011 Nov; 100(1):17-24. PubMed ID: 21763340
[TBL] [Abstract][Full Text] [Related]
12. Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.
Spiller K; Xi ZX; Li X; Ashby CR; Callahan PM; Tehim A; Gardner EL
Neuropharmacology; 2009 Jul; 57(1):60-6. PubMed ID: 19393252
[TBL] [Abstract][Full Text] [Related]
13. The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain models.
AlSharari SD; Carroll FI; McIntosh JM; Damaj MI
J Pharmacol Exp Ther; 2012 Sep; 342(3):742-9. PubMed ID: 22678099
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
Rogóz Z; Skuza G
Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794
[TBL] [Abstract][Full Text] [Related]
16. The effects of varenicline on sensory gating and exploratory behavior with pretreatment with nicotinic or 5-HT3A receptor antagonists.
Kucinski A; Wersinger S; Stachowiak EK; Becker C; Lippiello P; Bencherif M; Stachowiak MK
Behav Pharmacol; 2015 Feb; 26(1-2):217-26. PubMed ID: 25485645
[TBL] [Abstract][Full Text] [Related]
17. Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids.
Cunningham CS; McMahon LR
Psychopharmacology (Berl); 2013 Jul; 228(2):321-33. PubMed ID: 23494230
[TBL] [Abstract][Full Text] [Related]
18. Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.
Peng C; Stokes C; Mineur YS; Picciotto MR; Tian C; Eibl C; Tomassoli I; Guendisch D; Papke RL
J Pharmacol Exp Ther; 2013 Nov; 347(2):424-37. PubMed ID: 23959137
[TBL] [Abstract][Full Text] [Related]
19. Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration.
George O; Lloyd A; Carroll FI; Damaj MI; Koob GF
Psychopharmacology (Berl); 2011 Feb; 213(4):715-22. PubMed ID: 20924754
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
Redrobe JP; Bourin M
Psychopharmacology (Berl); 1998 Jul; 138(2):198-206. PubMed ID: 9718290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
